Guyana vs Russian Federation: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Guyana
0.1%
in 2024
Russian Federation
0.1%
in 2024
Guyana rank
134th
Russian Federation rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Guyana
- Russian Federation
How they compare
Guyana currently reports 0.1% against 0.1% in Russian Federation, a difference of 0.0%.
Across all 10 years both countries report, Russian Federation has been ahead every year.
Guyana ranks 134th and Russian Federation ranks 134th of 246 countries.
Head to head by decade
| Decade | Guyana | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Guyana or Russian Federation?
- Guyana, at 0.1% against 0.1% in Russian Federation as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Guyana and Russian Federation?
- 0.0%, with Guyana ahead.
- How many years of comparable data are there for Guyana and Russian Federation?
- 10 years are reported by both, from 2015 to 2024.
- How do Guyana and Russian Federation rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Guyana ranks 134th and Russian Federation ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.